The Biopatch antimicrobial dressing, from ETHICON, is supported by an evidence base of 14 randomised controlled trials for the prevention of CRBSIs and has seen a decrease in the risk of these infections by up to 69%.
This innovative technology has been awarded a Class B Recommendation from the new EPIC 3 Guidelines, a Category 1b recommendation from the Centers for Disease Control & Prevention (CDC) as well as Health Protection Scotland (HPS).